The use of oral prednisolone (2 mg/kg) to treat children admitted to hospital with acute asthma was assessed in a placebo controlled study. Children were further randomised to receive either 0-15 mg/kg salbutamol every 30 minutes for the first three hours of admission, or 5 mg salbutamol every one to four hours as needed. Treatment was double blind and the assessor was unaware of the nebuliser regimen given. Children were examined before and after treatment with salbutamol on arrival and reassessed four hours after admission. Seventy children completed the study. Seventeen (46%) of 37 children receiving prednisolone and six (9%) of 33 receiving placebo were fit for discharge after four hours of treatment. There was no significant difference between the two nebuliser regimens. Clinical parameters indicative of asthma severity were improved in all groups. Between group comparisons at reassessment showed higher peak flows in those receiving prednisolone and nebulisers every 30 minutes but differences were not significant for other parameters. Objective parameters indicating steroid efficacy over placebo were minimal. Despite this, those receiving prednisolone were more readily identifiable as being fit for discharge within four hours of treatment.
Systemic corticosteroids are often prescribed for the treatment of acute asthma. Although most paediatricians perceive these drugs as beneficial, the reported studies attempting to verify this have produced conflicting data. The inconsistencies between studies have been attributed to differences in study populations.' It has been suggested that many of the negative studies include large numbers of patients with asthma improving spontaneously and so the benefits from additional steroid usage are not apparent. This hypothesis is contradicted by several good studies providing evidence for the benefit of steroids in the treatment of asthma exacerbations at home in children2 3 and adults. 6 It is in the more severe cases requiring admission to hospital that the evidence is less consistent. Although some studies have suggested that steroids are beneficial in this context,7 8 there are several showing minimal or no benefit. [9] [10] [11] [12] [13] [14] Other studies in acute asthma have sought to optimise 12 agonist treatment. [15] [16] [17] Results suggest that high dose, frequent nebulisations, exceeding current licensing recommendations, are safe and more effective than less intensive regimens. It might be that the conflicting results from inpatient studies of steroid usage are due to differences in the extent to which concomitant bronchodilator treatment approaches the optimum dose.
Studies showing steroids to be of benefit have reported a wide timescale for the onset of clinical response. The effects of corticosteroids that are likely to benefit children with acute asthma are most commonly attributed to changes in protein synthesis mediated by RNA transcription. Although this might imply that effects would not be apparent until some time after initiating treatment, some studies have shown improvements within three to four hours.4 7 8 This study reassesses the early effects of a single dose of prednisolone in the treatment of acute asthma.7 The benefits of prednisolone over placebo were assessed with two different nebuliser regimens: our own practice of giving 5 mg salbutamol every one to four hours as thought necessary by nursing staff and 0-15 mg/kg salbutamol every 30 minutes for the first three hours of admission. (This latter regimen approximated to the maximum dose schedule used routinely that we were aware of when planning this study. 17) Responses to treatment were assessed four hours after starting treatment. The study was designed to determine whether the benefits of steroids could be identified when nebuliser treatment was intensified with these alternative regimens and to find out how the subsequent need for inpatient treatment was affected.
Patients and methods
The study was conducted at the Royal Alexandra Hospital for Sick Children in Brighton. The hospital admits 500-600 children annually with acute asthma of whom two thirds are self referred. Over a four month period (October 1990-January 1991) children aged over 18 months with acute asthma were considered for entry into the study depending on the availability of a single observer (GJC) to see each child within 30 minutes of arrival. Each child was assessed before and 10 minutes after 5 Table 1 shows that important covariates were well balanced between the four treatment groups. Table 2 shows the number of children in each treatment group who could be discharged when reassessed at four hours. Children receiving prednisolone plus nebulisers every 30 minutes were significantly more likely to be sent home than the reference group. This difference was significant at the 5%/o level. When the data from the four groups were combined, the effect of prednisolone in increasing the number of children that could be discharged is Table 6 gives the side effects considered attributable to asthma treatment. Tremor and hyperactivity were more commonly reported in those children receiving the more intensive nebuliser regimen but symptoms were mild and self limiting in most instances. Vomiting was more a feature of disease severity than any particular treatment group. Diary cards were given to the parents of the 23 children sent home. These were returned by all except three from children receiving prednisolone plus nebulisers every 30 minutes and one receiving prednisolone plus nebulisers every one to four hours. Mean scores for cough and wheeze in with asthma assessed as outpatients and receiving considerably less bronchodilator than in hospitals suggests that this does occur. [3] [4] [5] [6] Studies of patients with severe asthma, refractory to large doses of bronchodilators by inhalation and intravenously, have also shown the additional benefit of steroids with significant changes in lung function. 20 21 It appears that during severe asthma attacks bronchodilatation by P2 agonists is limited and the addition of steroids in this setting produces an independent quantifiable effect on lung function.
Like most inpatient studies, with more intensive bronchodilator treatment and comparable disease severity, our objective measurements of improvement after steroid treatment are minimal.4 9 14 We have shown that despite this the beneficial effects of steroids are readily appreciable. The more immediate and quantifiable benefits of bronchodilators should not preclude steroid use. Routine steroid treatment for all asthma admissions can facilitate the safe discharge of an increased number of children within a short period of treatment.
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